A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia
Samir S. Awad(Baylor College of Medicine), Marc Engelhardt(Basilea Pharmaceutica (Switzerland))
Cited by 225
Related Papers
Local variations in the epidemiology, microbiology, and outcome of necrotizing soft-tissue infections: a multicenter study
|The American Journal of Surgery|2011|136
Ceftobiprole for Treatment of Complicated <i>Staphylococcus aureus</i> Bacteremia
|New England Journal of Medicine|2023|98